Raez, Luis
Contact Info
Scholarly & Creative Works
selected publications
-
Article
-
2021Influence of Sex in the Molecular Characteristics and Outcomes of Malignant TumorsFull Text via DOI: 10.3389/fonc.2021.752918 Web of Science: 000715850100001
-
2021Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Full Text via DOI: 10.1016/j.lungcan.2021.08.010 Web of Science: 000702866700014
-
2021Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)Full Text via DOI: 10.2217/imt-2021-0019 Web of Science: 000641732500001
-
2021Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy. CLINICAL CANCER RESEARCH. 27:1019-1028.Full Text via DOI: 10.1158/1078-0432.CCR-20-3305 Web of Science: 000620168400017
-
2021The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerFull Text via DOI: 10.1016/j.cllc.2021.08.012
-
2020Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study). JOURNAL OF CLINICAL EPIDEMIOLOGY. 126:1-8.Full Text via DOI: 10.1016/j.jclinepi.2020.05.033 Web of Science: 000576195200001
-
2020Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards. JOURNAL OF CLINICAL ONCOLOGY. 38:633-+.Full Text via DOI: 10.1200/JCO.19.02297 Web of Science: 000517176600014
-
2020Clinical consequences of resistance to ALK inhibitors in non-small cell lung cancer. EXPERT REVIEW OF RESPIRATORY MEDICINE. 14:385-390.Full Text via DOI: 10.1080/17476348.2020.1721285 Web of Science: 000511643400001
-
2019Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP). THORACIC CANCER. 11:353-361.Full Text via DOI: 10.1111/1759-7714.13272 Web of Science: 000502076400001
-
2019Current knowledge of Ipilimumab and its use in treating non-small cell lung cancer. EXPERT OPINION ON BIOLOGICAL THERAPY. 19:509-515.Full Text via DOI: 10.1080/14712598.2019.1610380 Web of Science: 000476931600003
-
2019Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network. CANCER RESEARCH. 79.Full Text via DOI: 10.1158/0008-5472.CAN-18-1479 Web of Science: 000457394600020
-
2018Exosome-Based Detection of EGFR T790M in Plasma from Non-Small Cell Lung Cancer Patients. CLINICAL CANCER RESEARCH. 24.Full Text via DOI: 10.1158/1078-0432.CCR-17-3369 Web of Science: 000435462700024
-
2018Making Sense of Immunotherapy in Lung Cancer: What the Pulmonologist Needs to Know?. CURRENT PULMONOLOGY REPORTS. 7.Full Text via DOI: 10.1007/s13665-018-0200-9 Web of Science: 000433116800002
-
2018Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. NEW ENGLAND JOURNAL OF MEDICINE. 378.Full Text via DOI: 10.1056/NEJMoa1714448 Web of Science: 000425613900010
-
2017Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin AmericaFull Text via DOI: 10.1016/j.cllc.2016.05.003 Web of Science: 000504053200009
-
2016Checkpoints inhibitors in first line therapy of metastatic non-small cell lung cancer patients. TRANSLATIONAL CANCER RESEARCH. 5:S1443-S1448.Full Text via DOI: 10.21037/tcr.2016.12.14 Web of Science: 000393329400035
-
2015Entinostat (SNDX-275) for the treatment of non-small cell lung cancer. EXPERT OPINION ON INVESTIGATIONAL DRUGS. 24:1101-1109.
-
2014Immunotherapeutic Agents in Non-small-cell Lung Cancer Finally Coming to the Front Lines. CURRENT ONCOLOGY REPORTS. 16.
-
2014The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFR-Inhibitors: Did We Really Find the Target?. CURRENT DRUG TARGETS. 15:1284-1292.
-
2013Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer. CANCER BIOLOGY & THERAPY. 14:557-563.
-
2009Developing a vaccine for non-small-cell lung cancerFull Text via DOI: 10.3810/pgm.2009.09.2067
-
2007Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerFull Text via DOI: 10.1056/NEJMoa070956
-
-
Correction
-
2020Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) (vol 151, 102978, 2020). CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY.Full Text via DOI: 10.1016/j.critrevonc.2020.103058 Web of Science: 000574926800002
-
-
Editorial Material
-
2020Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps. JACC: CARDIOONCOLOGY. 535-538.Full Text via DOI: 10.1016/j.jaccao.2020.06.009 Web of Science: 000613114400027
-
2020Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of Immunotherapy. JCO GLOBAL ONCOLOGY. 784-788.Full Text via DOI: 10.1200/GO.20.00004 Web of Science: 000556801700003
-
2018Detection of epidermal growth factor receptor mutations in circulating tumor DNA: reviewing BENEFIT clinical trialFull Text via DOI: 10.21037/jtd.2018.11.22 Web of Science: 000456834700030
-
2018Old myths about old patients: the case of non-small cell lung cancer. TRANSLATIONAL LUNG CANCER RESEARCH.Full Text via DOI: 10.21037/tlcr.2018.09.24 Web of Science: 000454551800016
-
2018Tumor Type-Agnostic Treatment and the Future of Cancer Therapy. TARGETED ONCOLOGY.Full Text via DOI: 10.1007/s11523-018-0593-y Web of Science: 000446890500001
-
2016Neurotrophic tyrosine kinase gene fusions: another opportunity for targeting in lung cancer. LUNG CANCER MANAGEMENT.Full Text via DOI: 10.2217/lmt-2016-0003 Web of Science: 000374006000001
-
2009Cancer vaccines: A new therapeutic alternative for lung cancer therapy?. 727-728.Full Text via DOI: 10.2217/IMT.09.57
-
-
Letter
-
2020Anaphylactic Shock and Cardiac Arrest Secondary to Aprepitant. AMERICAN JOURNAL OF THERAPEUTICS. E640-E642.Full Text via DOI: 10.1097/MJT.0000000000001133 Web of Science: 000619165200020
-
2018Regarding the Congruence between 2 Circulating Tumor DNA Sequencing Assays. 1430.Full Text via DOI: 10.1001/jamaoncol.2018.2320
-
2018ROS-1 Rearrangements in Circulating Tumor Cells. JOURNAL OF THORACIC ONCOLOGY.Full Text via DOI: 10.1016/j.jtho.2017.11.127 Web of Science: 000432452900001
-
2018EGFR-RAD51 Fusion: A Targetable Partnership Originated from the Tumor Evolution?. e33-e34.Full Text via DOI: 10.1016/j.jtho.2017.10.005
-
2017Mutation of MET Y1230 as an Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping. e89-e90.Full Text via DOI: 10.1016/j.jtho.2017.02.017
-
2005Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer [10]. 4244-4245.Full Text via DOI: 10.1200/JCO.2004.00.5165
-
-
Meeting Abstract
-
2016Lung Cancer Chromosomal Aberrations and Gene Expression Profiles of Hispanics Living in the US or Latin America are Similar. JOURNAL OF THORACIC ONCOLOGY. S176-S176.Web of Science: 000427345100012
-
2016Lung Cancer Chromosomal Aberrations and Gene Expression Profiles of Hispanics Living in the US or Latin America are Similar. JOURNAL OF THORACIC ONCOLOGY. S187-S188.Web of Science: 000427345100029
-
2016Real World Use of Liquid Biopsy in Patients With Lung Adenocarcinoma and Correlation With Tumor Tissue Genetic Profile. JOURNAL OF THORACIC ONCOLOGY. S199-S200.Web of Science: 000427345100045
-
2015Genomic Analysis of Lung Cancer Tumors from Hispanic Patients Living in the US. JOURNAL OF THORACIC ONCOLOGY. S232-S232.Web of Science: 000370365100384
-
2013EXPLORING DISPARITIES IN HEALTH CARE OUTCOMES IN MINORITY POPULATIONS WITH SMALL (SCLC) AND NON-SMALL CELL LUNG CANCERS (NSCLC). JOURNAL OF THORACIC ONCOLOGY. S325-S325.Web of Science: 000339624901181
-
-
Review
-
2021Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer. 1165-1178.Full Text via DOI: 10.1080/14737159.2021.1985468 Web of Science: 000707822000001
-
2021Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer. 1647-1662.Full Text via DOI: 10.1016/j.jtho.2021.06.017 Web of Science: 000701853900008
-
2021Neuregulin 1 Gene (NRG1). A Potentially New Targetable Alteration for the Treatment of Lung CancerFull Text via DOI: 10.3390/cancers13205038 Web of Science: 000714000600001
-
2021Adjuvant therapy in non-small cell lung cancer: is targeted therapy joining the standard of care?. 1229-1235.Full Text via DOI: 10.1080/14737140.2021.1982387 Web of Science: 000699890100001
-
2021Profile of entrectinib in the treatment of ROS1-positive non-small cell lung cancer: Evidence to date. 192-198.Full Text via DOI: 10.1016/j.hemonc.2020.11.005
-
2021Reaching Across the Aisle: Cardio-Oncology Advocacy and Program BuildingFull Text via DOI: 10.1007/s11912-021-01059-1 Web of Science: 000640506800004
-
2020Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy. CANCER DISCOVERY. 1635-1644.Full Text via DOI: 10.1158/2159-8290.CD-20-0466 Web of Science: 000583736200020
-
2020A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation. TRANSLATIONAL LUNG CANCER RESEARCH. 2113-2119.Full Text via DOI: 10.21037/tlcr-20-601 Web of Science: 000582799700040
-
2020Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB). CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY.Full Text via DOI: 10.1016/j.critrevonc.2020.102978 Web of Science: 000541146300013
-
2020Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE.Full Text via DOI: 10.1177/1753466620938553 Web of Science: 000551965800001
-
2019The value of immunotherapy in head and neck cancer. EXPERT OPINION ON BIOLOGICAL THERAPY.Full Text via DOI: 10.1080/14712598.2019.1556637 Web of Science: 000454640500002
-
2018Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment. SEMINARS IN CANCER BIOLOGY.Full Text via DOI: 10.1016/j.semcancer.2018.01.015 Web of Science: 000446285900027
-
2018Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC. JOURNAL OF THORACIC ONCOLOGY.Full Text via DOI: 10.1016/j.jtho.2018.05.030 Web of Science: 000444520200018
-
2018Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression. TARGETED ONCOLOGY. 175-187.
-
2017New targets bring hope in squamous cell lung cancer: Neurotrophic tyrosine kinase gene fusions. 1268-1270.Full Text via DOI: 10.1038/labinvest.2017.91
-
2017The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer. 7-12.Full Text via DOI: 10.4081/oncol.2017.324
-
2016BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 32-39.
-
2016The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer. EXPERT OPINION ON INVESTIGATIONAL DRUGS. 385-392.
-
2015Entrectinib: A potent new TRK, ROS1, and ALK inhibitor. 1493-1500.Full Text via DOI: 10.1517/13543784.2015.1096344
-
2015Nintedanib in non-small cell lung cancer: From preclinical to approval. 164-172.Full Text via DOI: 10.1177/1753465815579608
-
2015cMET in NSCLC: Can we cut off the head of the Hydra? From the pathway to the resistance. 556-573.Full Text via DOI: 10.3390/cancers7020556
-
2014Immunotherapy: Is a minor god yet in the pantheon of treatments for lung cancer?. 1173-1187.Full Text via DOI: 10.1586/14737140.2014.952287
-
2014Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor. EXPERT OPINION ON BIOLOGICAL THERAPY. 15-26.
-
2014Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors. CANCER TREATMENT REVIEWS. 990-1004.
-
2013Targeting angiogenesis in non-small-cell lung cancer: A focus on current approaches and future developments. 503-517.Full Text via DOI: 10.2217/cpr.13.27
-
2012Emerging role of multikinase inhibitors for refractory thyroid cancer. 257-265.Full Text via DOI: 10.2147/BTT.S24465
-
2012Novel molecular targeted therapies for refractory thyroid cancer. 736-745.Full Text via DOI: 10.1002/hed.21755
-
2012Epidermal growth factor vaccine in non-small-cell lung cancer. EXPERT REVIEW OF ANTICANCER THERAPY. 439-445.Full Text via DOI: 10.1586/ERA.12.24 Web of Science: 000303228800009
-
2011Active immunotherapy for non-small-cell lung cancer: Moving toward a reality. 1599-1605.Full Text via DOI: 10.1586/era.11.155
-
2011The role of proteasome inhibition in nonsmall cell lung cancerFull Text via DOI: 10.1155/2011/806506
-
2011Development of targeted therapy for squamous cell carcinomas of the head and neck. 373-386.Full Text via DOI: 10.1586/era.10.193
-
2011Immunotherapy as a strategy for the treatment of non-small-cell lung cancer. 43-54.Full Text via DOI: 10.2217/thy.10.84
-
2010Tumor immunogenicity and responsiveness to cancer vaccine therapy: The state of the art. 105-112.Full Text via DOI: 10.1016/j.smim.2010.02.001
-
2010Accelerated second-line or maintenance chemotherapy versus treatment at disease progression in NSCLC. 549-557.Full Text via DOI: 10.1586/era.10.30
-
2010Nasopharyngeal carcinoma: Alternative treatment options after disease progression. 377-386.Full Text via DOI: 10.1586/ERA.10.1
-
2010Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer. 18-24.Full Text via DOI: 10.3816/CLC.2010.n.003
-
2009How is gene-expression profiling going to challenge the future management of lung cancer?. 827-835.Full Text via DOI: 10.2217/fon.09.60
-
2009Epidermal growth factor receptor pathway as therapeutic development in head and neck cancers: Present and future. 137-148.Full Text via DOI: 10.1007/s12156-009-0022-7
-
2009Gene expression profiling and non-small-cell lung cancer: Where are we now?. 168-173.Full Text via DOI: 10.3816/CLC.2009.n.023
-
2009Second-line therapy for non-small-cell lung cancer. 91-98.Full Text via DOI: 10.3816/CLC.2009.n.011
-
2008Controversies in the management of stage IIIA non-small-cell lung cancer. 1913-1929.Full Text via DOI: 10.1586/14737140.8.12.1913
-
2007Allogeneic tumor-cell-based vaccines secreting endoplasmic reticulum chaperone gp96. 1679-1688.Full Text via DOI: 10.1517/14712598.7.11.1679
-
2007New targets for non-small-cell lung cancer therapy. 1423-1437.Full Text via DOI: 10.1586/14737140.7.10.1423
-
2006Induction chemotherapy in the management of squamous cell carcinoma of the head and neck. 1205-1215.Full Text via DOI: 10.1586/14737140.6.9.1205
-
2006Heat Shock Protein-Based Cancer Vaccines. 637-659.Full Text via DOI: 10.1016/j.hoc.2006.02.007
-
2005DNA methylation: Its role in lung carcinogenesis and therapeutic implications. 667-679.Full Text via DOI: 10.1586/14737140.5.4.667
-
2005Combined modality therapy for limited-disease Small Cell Lung Cancer. 69-74.Full Text via DOI: 10.1007/s11864-005-0014-1
-
2004
-
Contact
full name
- Luis Raez
